Discontinued — last reported Q3 '22
Gene-based and esoteric testing services — Net revenues
Quest Diagnostics Gene-based and esoteric testing services — Net revenues increased by 6.1% to $835.00M in Q3 2022 compared to the prior quarter. Year-over-year, this metric grew by 29.3%, from $646.00M to $835.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful expansion into high-value diagnostic markets and growing adoption of precision medicine, while a decrease may signal increased competition in specialized testing or shifts in healthcare reimbursement policies.
Detailed definition
This metric represents the total net revenue generated from specialized diagnostic testing services, including molecular...
Peer comparison
Peers in the diagnostic and laboratory services industry report similar revenue streams under categories like 'Specialty Testing' or 'Molecular Diagnostics,' which are generally tracked to measure innovation and high-margin service growth.
dgx_segment_gene_based_and_esoteric_testing_services_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|---|
| Value | $673.00M | $646.00M | $906.00M | $739.00M | $787.00M | $835.00M |
| QoQ Change | — | -4.0% | +40.2% | -18.4% | +6.5% | +6.1% |
| YoY Change | — | — | — | — | +16.9% | +29.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Quest Diagnostics's gene-based and esoteric testing services — net revenues?
- Quest Diagnostics (DGX) reported gene-based and esoteric testing services — net revenues of $835.00M in Q3 2022.
- How has Quest Diagnostics's gene-based and esoteric testing services — net revenues changed year-over-year?
- Quest Diagnostics's gene-based and esoteric testing services — net revenues increased by 29.3% year-over-year, from $646.00M to $835.00M.
- What does gene-based and esoteric testing services — net revenues mean?
- Revenue generated from high-complexity, specialized genetic and molecular diagnostic tests.